Literature DB >> 12236420

Intestinal microsporidiosis in HIV-infected children with diarrhea.

Darawan Wanachiwanawin1, Kulkanya Chokephaibulkit, Punpob Lertlaituan, Jeerawan Ongrotchanakun, Pisith Chinabut, Kleophant Thakerngpol.   

Abstract

Intestinal microsporidiosis is a common opportunistic disease associated with diarrhea in adult AIDS patients in Thailand; the data regarding this infection in children are scarce. The present study was designed to investigate the prevalence and clinical features of intestinal microsporidiosis in hospitalized HIV-infected and uninfected (free of HIV) children with diarrhea. Of the 95 HIV-infected children and 87 uninfected children, 24 (25.3%) and 13 (14.9%) respectively were diagnosed with intestinal microsporidiosis. Species identification of microsporidia spores, by transmission electron microscopy, demonstrated Enterocytozoon bieneusi in 5 cases. Cryptosporidium parvum was a common coinfective parasite; pneumonia was the most frequent concurrent disease found in children with intestinal microsporidiosis. Malnutrition was commoner in the HIV-infected group (79.2% vs 23.1%; p = 0.003). This study indicates that intestinal microsporidiosis is an important disease in both HIV-infected and uninfected Thai children with diarrhea.

Entities:  

Mesh:

Year:  2002        PMID: 12236420

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  10 in total

Review 1.  Zoonotic potential of the microsporidia.

Authors:  Alexander Mathis; Rainer Weber; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  Carriage rate of Enterocytozoon bieneusi in an orphanage in Bangkok, Thailand.

Authors:  Watcharee Pagornrat; Saovanee Leelayoova; Ram Rangsin; Peerapan Tan-Ariya; Tawee Naaglor; Mathirut Mungthin
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

3.  New insights of Microsporidial infection among asymptomatic aboriginal population in Malaysia.

Authors:  Tengku Shahrul Anuar; Hesham M Al-Mekhlafi; Fatmah Md Salleh; Norhayati Moktar
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 4.  Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

Authors:  Veeranoot Nissapatorn; Nongyao Sawangjaroen
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 5.  Severe acute malnutrition and infection.

Authors:  Kelsey D J Jones; James A Berkley
Journal:  Paediatr Int Child Health       Date:  2014-12       Impact factor: 1.990

Review 6.  Prevalence of Cryptosporidium, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis.

Authors:  Ze-Dong Wang; Quan Liu; Huan-Huan Liu; Shuang Li; Li Zhang; Yong-Kun Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

7.  Design and application of a novel two-amplicon approach for defining eukaryotic microbiota.

Authors:  Ana Popovic; Celine Bourdon; Pauline W Wang; David S Guttman; Wieger Voskuijl; Michael E Grigg; Robert H J Bandsma; John Parkinson
Journal:  Microbiome       Date:  2018-12-20       Impact factor: 14.650

8.  Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis.

Authors:  Ehsan Ahmadpour; Hanie Safarpour; Lihua Xiao; Mehdi Zarean; Kareem Hatam-Nahavandi; Aleksandra Barac; Stephane Picot; Mohammad Taghi Rahimi; Salvatore Rubino; Mahmoud Mahami-Oskouei; Adel Spotin; Sanam Nami; Hossein Bannazadeh Baghi
Journal:  Parasite       Date:  2020-04-30       Impact factor: 3.000

9.  Epidemiology of Enterocytozoon bieneusi Infection in Humans.

Authors:  Olga Matos; Maria Luisa Lobo; Lihua Xiao
Journal:  J Parasitol Res       Date:  2012-10-03

10.  Microsporidiosis and malnutrition in children with persistent diarrhea, Uganda.

Authors:  Siobhan M Mor; James K Tumwine; Elena N Naumova; Grace Ndeezi; Saul Tzipori
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.